GoodRx has officially entered the weight loss drug market by offering an exclusive discount on the once-daily oral medication Qsymia. Through GoodRx, patients with a valid prescription can ...

Cyclosporine-drug interactions in adult transplant patients and the impact of age were studied. The medical records of transplant patients receiving cyclosporine therapy were identified. Data on ...

If you're one of the many Americans struggling to afford prescription medication, GoodRx's deal with Walgreens could help you save the next time you're at the pharmacy. Prices on nearly 200 ...

This leaflet answers some common questions about Cyclosporin Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

Downgrading GoodRx to a sell rating on recent decline fundamentals. GoodRx's revenue growth is decelerating, with significant reliance on retail partnerships and cyclical transactional revenue ...

Shayna Chamberlin's monthly prescription went from $210 to $37. She credits GoodRx. "It saved me $300 this year alone," Chamberlin said. "I know how insane health care prices are as someone who ...

Challenged by the findings of Hojo et al., we assessed whether the observed effect of CsA was dependent on CsA dose or CsA treatment duration, and how the observed incidence of cancer in our study ...

Twelve medications with previously unreported or unconfirmed pharmacokinetic interactions with cyclosporine were identified as interacting by using routine data on cyclosporine pharmacokinetics ...

GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The firm offers consumers free access to transparent and lower prices for brand and generic ...

SANTA MONICA, Calif., October 31, 2024--Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced the rollout of its new e-commerce solution, with Opill® as ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...